Wealthcare Advisory Partners LLC Has $2.73 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Wealthcare Advisory Partners LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 59.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 5,186 shares of the healthcare conglomerate’s stock after purchasing an additional 1,942 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in UnitedHealth Group were worth $2,730,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. International Assets Investment Management LLC lifted its position in shares of UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after buying an additional 2,348,107 shares during the period. Jennison Associates LLC grew its stake in shares of UnitedHealth Group by 49.3% during the fourth quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock worth $1,904,670,000 after purchasing an additional 1,195,352 shares during the period. Mawer Investment Management Ltd. boosted its position in shares of UnitedHealth Group by 75.0% during the third quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock worth $1,014,002,000 after buying an additional 862,024 shares during the period. California Public Employees Retirement System boosted its position in shares of UnitedHealth Group by 35.9% during the fourth quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock worth $1,627,311,000 after buying an additional 815,822 shares during the period. Finally, Ameriprise Financial Inc. raised its holdings in UnitedHealth Group by 20.1% during the third quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock worth $1,879,245,000 after acquiring an additional 623,631 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded up $1.93 during trading on Monday, reaching $494.38. 2,024,579 shares of the company’s stock were exchanged, compared to its average volume of 4,385,424. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a market cap of $454.87 billion, a P/E ratio of 30.22, a PEG ratio of 1.43 and a beta of 0.55. The firm’s 50-day moving average price is $481.70 and its 200 day moving average price is $512.16.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the prior year, the firm earned $6.26 EPS. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

UNH has been the topic of several analyst reports. Royal Bank of Canada dropped their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Stephens reiterated an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. Truist Financial restated a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Finally, TD Cowen reduced their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.